🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07525518
Enrolling by invitation Observational

Okami Medical ALPHA Registry

NCT07525518 · tracked via the Priya Life Science USA tracker
Sponsor
Okami Medical, Inc.
Phase
Observational
Started
2026-03-31
Last updated
2026-07-21

Condition(s) studied

Arterial BleedPulmonary Arteriovenous MalformationEmbolizationHemorrhage

Investigational drug(s) / intervention(s)

LOBO Vascular Occlusion System

LOBO Vascular Occlusion System: LOBO Vascular Occlusion System

Study summary

This registry will provide insights into the use of Okami Medical devices in real-world clinical and study effectiveness and safety of Okami Medical devices.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * The patient or their legally authorized representative is willing and able to provide informed consent per local requirements * Has or will receive treatment with an eligible Okami Medical device * Age ≥ 18 years Exclusion Criteria: * Is or will be inaccessible for registry follow-up * Meets exclusion criteria required by local requirements * Current or planned participation in a drug or device study that would interfere with participation in this registry or confound the results of this registry in the opinion of the investigator

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
University of Colorado Aurora Colorado
UMASS Chan Medical School Worcester Massachusetts
University of North Carolina at Chapel Hill Chapel Hill North Carolina
Charlotte Radiology Charlotte North Carolina

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07525518 on ClinicalTrials.gov ↗ ← All trials in the USA